News & Updates

InSitu Biologics is off to a fast start in 2021.  We completed a successful financing round, made great strides in our R&D efforts, and held our first […]

Insitu Biologics had several key accomplishments in 2020, setting the stage for an even better 2021. We significantly reduced our shareholders-of-record, renegotiated and renewed our license agreement […]

InSitu Biologics has made considerable progress executing our business plan over the past several months, even in the midst of ongoing COVID-19 challenges.  We recently raised over […]

InSitu Biologics has continued to make great strides over the past few months. We have successfully submitted our Pre-IND application to the FDA, as well as applied […]